A carregar...
Does market exclusivity hinder the development of Follow-on Orphan Medicinal Products in Europe?
BACKGROUND: We determined whether the market exclusivity incentive of the European Orphan Drug Regulation results in a market monopoly or that absence of another Orphan Medicinal Product (OMP) for the same rare disorder, a so-called follow-on OMP, is a matter of time or market size. In the interest...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3185263/ https://ncbi.nlm.nih.gov/pubmed/21892964 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1750-1172-6-59 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|